好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Suppression of NF-[kappa]B Activation and Inflammation in Glial Cells by RNS60, a Novel Therapeutic: Implications for Neurodegenerative Disorders
Movement Disorders
(-)
006
Authors/Disclosures
Saurabh Khasnavis No disclosure on file
No disclosure on file
Avik Roy, PhD (Rush University Medical Center) No disclosure on file
No disclosure on file
Supurna Ghosh, PhD (Revalesio) Dr. Ghosh has received personal compensation for serving as an employee of Revalesio Corporation.
Richard Watson, MD (Revalesio Corporation) No disclosure on file
No disclosure on file
Liesly Lee, MD (Sunnybrook Health Sciences Centre) Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.